Arkolith/Insider Trading/DCPH/Form 4

Hoerter Steven L.

President and CEO, DirectorDeciphera Pharmaceuticals, Inc. (DCPH) · full profile →Form 4 · filed Feb 16, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$481K
Net Open-Market Flow
-$481K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2023Sell(S)30K$16.00$481K8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2023Grant(A)250K—$0250K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-010062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML